IMCR Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 107557 min ago

@ $71.91

Wydano: 14 vas. 2024 @ 22:47

Zwrot: -18.70%

Poprzedni sygnał: vas. 14 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: -2.49 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases...

Stats
Dzisiejszy wolumen	403 551
Średni wolumen	512 688
Kapitalizacja rynkowa	2.91B
EPS	$0 ( 2024-02-28 )
Następna data zysków	( $-0.320 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-41.17
ATR14	$0.0510 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	St Leger Tina Amber	Sell	4 375	Employee Share Option (Right to Buy)
2024-04-01	St Leger Tina Amber	Buy	4 375	Ordinary Shares
2024-04-01	St Leger Tina Amber	Sell	4 375	Ordinary Shares
2024-02-28	Berman David M	Sell	36 509	Employee Share Option (Right to Buy)
2024-02-28	Berman David M	Buy	36 509	Ordinary Shares

INSIDER POWER
-75.94
Last 63 transactions
Buy: 607 651 \| Sell: 4 752 433

Wolumen Korelacja

Długi: 0.49 (neutral)

Krótki: 0.68 (moderate)

Signal:(74.516) Neutral

Immunocore Holdings plc Korelacja

10 Najbardziej pozytywne korelacje
AMRB	0.859
LWAC	0.837
MMAC	0.835

10 Najbardziej negatywne korelacje
SVAC	-0.83
TLGT	-0.821

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Immunocore Holdings plc Korelacja - Waluta/Towar

0.62
( weak )

0.55
( weak )

0.00
( neutral )

0.62
( weak )

-0.38
( neutral )

-0.56
( weak negative )

Immunocore Holdings plc Finanse

Annual	2023
Przychody:	$249.43M
Zysk brutto:	$248.39M (99.58 %)
EPS:	$-0.00110

FY	2023
Przychody:	$249.43M
Zysk brutto:	$248.39M (99.58 %)
EPS:	$-0.00110

FY	2022
Przychody:	$143.74M
Zysk brutto:	$143.28M (99.68 %)
EPS:	$-0.900

FY	2021
Przychody:	$26.52M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.10

Financial Reports:

No articles found.

Immunocore Holdings plc

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.